Danaher (DHR) Q1 Earnings Beat, Biotechnology Sales Dip Y/Y

Danaher Corporation’s (DHR) first-quarter 2024 adjusted earnings (excluding 47 cents from non-recurring items) of $1.92 per share surpassed the Zacks Consensus Estimate of$1.72. The bottom line declined 27.1% year over year.Danaher’s net sales of $5.8 billion outperformed the consensus estimate of$5.6 billion. However, the metric declined 2.5% year over year due to lower core sales in the Biotechnology segment.Organic sales in the quarter decreased 4%. Foreign-currency translations and acquisitions had a ...